- BGN21.00m
- BGN27.14m
- BGN15.82m
- 64
- 16
- 22
- 22
Annual income statement for Etropal AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.67 | 11.7 | 6.75 | 11.2 | 15.8 |
Cost of Revenue | |||||
Gross Profit | 3.07 | 1.09 | 2.55 | 3.56 | 4.28 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7.57 | 15.1 | 7.26 | 11 | 15.5 |
Operating Profit | 0.105 | -3.41 | -0.511 | 0.196 | 0.334 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.025 | -3.46 | -0.783 | -0.13 | 0.045 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.026 | -3.41 | -0.81 | -0.123 | 0.044 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.024 | -3.44 | -0.718 | -0.028 | 0.089 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.024 | -3.44 | -0.718 | -0.028 | 0.089 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.005 | -0.688 | -0.144 | -0.006 | 0.018 |
Dividends per Share |